An open label neoadjuvant study to assess the effect of Avastin on tumor response in patients with inflammatory or locally advanced breast cancer
Phase of Trial: Phase II
Latest Information Update: 09 Mar 2016
At a glance
- Drugs Bevacizumab (Primary) ; Cyclophosphamide; Epirubicin; Fluorouracil; Paclitaxel
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Roche
- 02 Nov 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 May 2013 Planned end date changed from 1 Dec 2015 to 1 Sep 2015 as reported by ClinicalTrials.gov.
- 15 Mar 2011 Planned end date changed from 1 Apr 2012 to 1 Dec 2015 as reported by ClinicalTrials.gov.